Patrick is a Medical Affairs consultant with over 30 years of experience within the pharmaceutical industry.  His area of focus and expertise is Medical Affairs functional capabilities, where he helps organizations harmonize and transform those capabilities to enhance efficiencies, increase productivity, and create value.

Patrick is currently the CEO of phactMI, a non-profit association representing medical information leadership of 30+ pharma companies.  PhactMI is an industry-wide consortium that focuses on increasing the awareness, credibility, and access to medical information.

Prior to joining phactMI, Patrick worked at Bristol-Myers Squibb where he held various leadership roles within the R&D organization.  He led the US Clinical Site Monitoring organization in R&D operations and implemented the original Oncology and Immunocience field Medical teams in US Medical Affairs.  Patrick’s global achievement at BMS was leading the implementation of a Field Medical capability in Europe, in support of several key launches.

Patrick was a member of the Global Medical leadership team and provided executive sponsorship for several key initiatives and programs including: developing new leaders through the BMS-Rutgers PharmD program; implementing new global systems and capabilities in support of a multichannel, customer centric strategy; and helping to transform the organization to a specialty care biopharma model.

Just prior to leaving BMS, Patrick led the globalization of the Medical Information capability by harmonizing customer engagement through the implementation of a global medical contact center, centralizing medical content creation and curation, and implementing a multichannel technology solution.

Patrick is a Physician Assistant by training and holds a Masters of Science degree in business administration and human resources management.

Dr. Gail Cawkwell has served as SVP, Medical Affairs, Safety & Pharmacovigilance of Intercept Pharmaceuticals since September 2018, having previously served as SVP, Medical Affairs since February 2018. Prior to joining Intercept, Dr. Cawkwell worked for Purdue Pharma L.P., where she served as Special Advisor to the Board of Directors from September 2017 to February 2018, Chief Medical Officer from January 2015 to September 2017 and VP, Medical Affairs from November 2014 to January 2015. From 2000 to November 2014, Dr. Cawkwell served in a number of roles of increasing responsibility at Pfizer Inc., including most recently as Vice President Medicine Team Lead for Pfizer’s tofacitinib franchise. Dr. Cawkwell also served as a Clinical Instructor of Pediatrics at Columbia Presbyterian Health Center from 2002 to 2015 and previously held several other clinical and academic posts. Dr. Cawkwell received her Ph.D. from the University of Cincinnati, her M.D. from McGill University in Montreal, Canada and her bachelor’s degree from Duke University